Funding for this research was provided by:
Foundation Johanna Duermueller-Bol
Sandoz Pharmaceuticals Switzerland (PO 3003668404, PO 3003668404)
Received: 25 January 2022
Accepted: 19 October 2022
First Online: 5 November 2022
: This study was performed in line with the principles of the Declaration of Helsinki. Approval was granted by the Ethics Committee of the Canton of Bern (Switzerland) in December 2018 (Project-ID 2018–01583). Informed consent was obtained from all patients.
: Not applicable. We only used anonymized data.
: TF declares that he has no competing interest. JB declares that she has no competing interest. BEG declares that she has no competing interest.